Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Cipla Duolin 3 Respules 5x3 ml

Duolin 3 Respules is a combination bronchodilator used to manage and treat Chronic Obstructive Pulmonary Disease (COPD), asthma, and bronchitis. It contains Levosalbutamol (1.25mg) and Ipratropium (500mcg), which work synergistically to relax airway muscles and improve airflow, reducing breathlessness, wheezing, and chest tightness.

₹87.29
In stock
SKU
SBDU06543
Price: 77.94 (Inclusive of 12% GST)
- +
Cipla Duolin 3 Respules 5x3 ml is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Dual-action formulation: Combines beta-agonist and anticholinergic bronchodilators

  • Fast relief: Begins acting within minutes, with effects lasting for hours

  • Nebulizer-friendly: Ideal for patients who cannot use inhalers effectively

  • Symptom control: Relieves shortness of breath, cough, and wheezing

  • Convenient dosage form: Unit-dose respules ensure accurate delivery

  • Trusted brand: Manufactured by Cipla, a leading respiratory care brand

Technical Details
Technical Specification
  • Brand Name: Duolin 3 Respules

  • Salt Composition: Levosalbutamol (1.25mg) + Ipratropium (500mcg)

  • Dosage Form: Respules (Nebulization Solution)

  • Route of Administration: Inhalation via nebulizer

  • Pack Size: 5 strips x 3 ml each (15 respules total)

  • Manufacturer / Marketer: Cipla Ltd

  • Therapeutic Class: Bronchodilator / Respiratory Medicine

  • Storage Conditions: Store below 30°C, protect from light and moisture

  • Prescription Required: Yes

  • 5.0 respules in 1 packet
  • Effective bronchodilation for improved breathing in COPD and asthma

  • Convenient for elderly and pediatric use through nebulizer

  • Reduces hospital visits by preventing acute flare-ups

  • Unit-dose packing eliminates risk of dosage errors

  • Safe for long-term management under medical supervision

  • Better lung penetration via nebulization compared to inhalers in some patients

Your Practice might also need
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.